Study shows AstraZeneca pill can cut deaths from a type of lung cancer in half

AUSTIN (KXAN) – An AstraZeneca drug has been shown to reduce the risk of death in some lung cancer patients by more than half, according to the research.
Results from a three-year-long clinical trial were released in early June and published in the Journal of New England Medicine. The data shows that when researchers administered the drug osimertinib to patients, there was a clinically meaningful improvement in overall survival compared to patients who received a placebo. “It ba